News

Ophthalmologist offers insights into the value of technology in diabetic retinopathy.

The device offers a shortened procedure time and efficient, effective SMILE for patients with myopia, with or without astigmatism.

The Visumax 800 boasts a faster laser pulse repetition rate for shorter procedures

The initiative marks the second annual ROP Awareness week, running from 24 February to 2 March, 2025

Bonnie Henderson, MD, founder and program director of the EnVision Summit, talked with Ophthalmology Times about the evolution of the conference and how it brings optometrists and ophthalmologists together to learn, discuss shared problems, and facilitate co-management in a family-friendly environment.

Italian investigators reported that ocular surface conditions such as dry eye disease are key factors in perioperative outcomes, even when patients achieve 20/20 vision.

The funding will help further the glaucoma program alongside new board member Carol Gallagher.

Monofocal IOLs, along with advanced phacoemulsification technology, offer tailored solutions.

Arctic Vision has a commercial collaboration agreement with Santen Pharmaceutical Co., Ltd. to commercialize ARVN001 for the treatment of UME.

The biosimilar to aflibercept (Eylea) had already received approval in the EU and US.

Incoming directors bring diverse expertise to help the ASO protect ophthalmic care and advocate for patients.

The researchers successfully tested the robot using enucleated pig eyes.

At the Envision Summit 2025 in San Juan, Puerto Rico, Kristen Nwanyanwu, MD, MBA, MHS, joined by her children, discussed her talk on eradicating TRD and the family-friendly environment of the conference.

The biosimilar to aflibercept (Eylea) has already received approval in the EU and US

The new formula will help relieve temporary symptoms caused by dryness of the eye.

Shameema Sikder, MD; and T. Y. Alvin Liu, MD, highlight the technology’s role in bridging challenges and successes for clinical practice.

Francesco Bandello, MD, FEBO, discusses the Diabetic Eye Conditions Coalition and a five-point call to action

Amniotic membrane tissue offers a number of advantages to patients.

The state-of-the-art facility more than doubles the institute’s footprint, enhancing patient care, research, and education.

Italian investigators reported that ocular surface conditions such as dry eye disease are key factors in perioperative outcomes, even when patients achieve 20/20 vision

Clinician highlights a novel complication of atropine treatment in a teenage patient.

A PDUFA date has been set for October 20, 2025. If approved, Epoxia will be the first epi-on corneal crosslinking on the market.

The imaging system is designed to enable secure, real-time remote monitoring around the clock, from virtually any location.

At the Envision Summit 2025 in San Juan, Puerto Rico, retina program chairs Geeta Lalwani, MD, and Majda Hadziahmetovic, MD, discussed Hadziahmetovic's presentation on deep learning models of neovascular AMD as well as their time at the conference.

This research project, titled, “A Generalizable Deep Learning Platform for Unifying Quantification of Experimental Autoimmune Uveitis.”

According to Apellis and Sobi, pegcetacoplan (Aspaveli) first received marketing authorisation for treatment of paroxysmal nocturnal hemoglobinuria.

Prevent Blindness will be sharing a variety of free educational resources to the public and professionals during the awareness week, which will be held February 24, 2025, through March 2, 2025.

At the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal degenerations that sidetracks the current "status quo" therapies of AAV-based replacement and CRISPR-Cas9 genome editing.